A detailed history of Tritonpoint Wealth, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Tritonpoint Wealth, LLC holds 56,706 shares of ABT stock, worth $6.48 Million. This represents 0.58% of its overall portfolio holdings.

Number of Shares
56,706
Previous 56,770 0.11%
Holding current value
$6.48 Million
Previous $5.9 Billion 8.08%
% of portfolio
0.58%
Previous 0.57%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$100.07 - $118.13 $6,404 - $7,560
-64 Reduced 0.11%
56,706 $6.38 Billion
Q2 2024

Aug 12, 2024

SELL
$100.73 - $112.44 $192,595 - $214,985
-1,912 Reduced 3.26%
56,770 $5.9 Billion
Q1 2024

Apr 25, 2024

SELL
$109.52 - $120.96 $691,837 - $764,104
-6,317 Reduced 9.72%
58,682 $6.5 Billion
Q4 2023

Jan 24, 2024

BUY
$90.19 - $110.4 $5.86 Million - $7.18 Million
64,999 New
64,999 $7.15 Billion

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $200B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Tritonpoint Wealth, LLC Portfolio

Follow Tritonpoint Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tritonpoint Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tritonpoint Wealth, LLC with notifications on news.